Inventor
Shay Soker
Inventor
Greensboro, NC, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides15%
C12NMicroorganisms or enzymes13%
A61LMethods or apparatus for sterilising materials or objects in general9%
A61FFilters implantable into blood vessels6%
B82YSpecific uses or applications of nanostructures3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
C08LCompositions of macromolecular compounds1%
D01DMechanical methods or apparatus in the manufacture of artificial filaments, threads, fibres, bristles or ribbons1%
PatentTitleYear
10,913,933Bioengineered liver constructs and methods relating thereto202110,052,350Fabrication of gelatin hydrogel sheet for the transplantation of corneal endothelium20189,938,502Tissue-specific extracellular matrix with or without tissue protein components for cell culture20189,707,256'Methods of making endothelial scaffolds'20179,163,331'Electrospun cell matrices'20159,062,346'Transcriptional profiling of stem cells and their multilineage differentiation'20159,056,093'Regeneration of pancreatic islets by amniotic fluid stem cell therapy'20158,940,292'Enhancement of angiogenesis to grafts using cells engineered to produce growth factors'20158,889,620'Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor'20148,628,572'Corneal endothelial scaffolds and methods of use'20148,529,905'Soluble inhibitors of vascular endothelial growth factor and use thereof'20138,491,457'Tissue engineered blood vessels'20138,153,585'Peptide antagonists of vascular endothelial growth factor and methods of use thereof'20127,883,847'Transcriptional profiling of stem cells and their multilineage differentiation'20117,736,655'Soluble inhibitors of vascular endothelial growth factor and use thereof'20107,731,959'Antagonists of neuropilin receptor function and use thereof'20107,666,393'Methods for assessing antiangiogenic agents'20107,531,503'Cell scaffold matrices with incorporated therapeutic agents'20097,414,027'Peptide antagonists of vascular endothelial growth factor'20087,335,357'Antagonists of neuropilin receptor function and use thereof'20087,273,612'Soluble inhibitors of vascular endothelial growth factor and use thereof'20076,777,534'Peptide antagonists of vascular endothelial growth factor'20046,635,421'Neuropilins and use thereof in methods for diagnosis and prognosis of cancer'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2014Patents assigned to CHILDRENS MEDICAL CENTER (9)· patent assignee history
2003–2010Based in Brookline, MA, US· patent location history
2009–2021Patents assigned to UNIV WAKE FOREST HEALTH SCIENCES (12)· patent assignee history
2009–2021Based in Greensboro, NC, US· patent location history
2012–2018Patents assigned to SOKER SHAY (10)· patent assignee history
2012–2014Patents assigned to KLAGSBRUN MICHAEL (3)· patent assignee history
2013–2018Patents assigned to ATALA ANTHONY (5)· patent assignee history
2014Based in Winston-Salem, NC, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV WAKE FOREST HEALTH SCIENCES | 12 | 2009–2021 |
| SOKER SHAYself | 10 | 2012–2018 |
| CHILDRENS MEDICAL CENTER | 9 | 2003–2014 |
| ATALA ANTHONY | 5 | 2013–2018 |
| KLAGSBRUN MICHAEL | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Greensboro, NC, US | 16 | 2009–2021 |
| Brookline, Massachusetts, US | 6 | 2003–2010 |
| Winston-Salem, NC, US | 1 | 2014 |